XML 20 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2024
Mar. 18, 2025
Jun. 30, 2024
Document and Entity Information      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2024    
Document Transition Report false    
Securities Act File Number 001-39202    
Entity Registrant Name ANNOVIS BIO, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 26-2540421    
Entity Address, Address Line One 101 Lindenwood Drive, Suite 225    
Entity Address, City or Town Malvern    
Entity Address, State or Province PA    
Entity Address, Postal Zip Code 19355    
City Area Code 484    
Local Phone Number 875-3192    
Title of 12(b) Security Common Stock, par value $0.0001 per share    
Trading Symbol ANVS    
Security Exchange Name NYSE    
Entity Current Reporting Status Yes    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period true    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 51,312,050
Entity Common Stock, Shares Outstanding   19,486,231  
Document incorporated by reference

Certain portions, as expressly described in this report, of the registrant’s proxy statement for the 2025 Annual Meeting of the Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.

    
Entity Central Index Key 0001477845    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Amendment Flag false    
Auditor Firm ID 42    
Auditor Name Ernst & Young LLP    
Auditor Location Philadelphia, Pennsylvania